Specificities of the Cutoff Value (PAC ≥ 30.85 ng/dL) for Predicting Positive Results in CCT or SIT Separately for Each Baseline PRA
Baseline PRA Levels (ng/mL/h) . | Specificity of the Cutoff Value (PAC ≥ 30.85 ng/dL) for Predicting Positive Result in Each Test (%) . | |
---|---|---|
. | Captopril Challenge Test . | Saline Infusion Test . |
≤ 0.3 | 96.5 | 100 |
≤ 0.4 | 97.2 | 100 |
≤ 0.5 | 96.4 | 100 |
≤ 0.6 | 97.0 | 100 |
≤ 0.7 | 95.0 | 99.1 |
≤ 0.8 | 95.0 | 99.1 |
≤ 1.0 | 93.1 | 99.1 |
> 1.0 | 90.7 | 99.1 |
Baseline PRA Levels (ng/mL/h) . | Specificity of the Cutoff Value (PAC ≥ 30.85 ng/dL) for Predicting Positive Result in Each Test (%) . | |
---|---|---|
. | Captopril Challenge Test . | Saline Infusion Test . |
≤ 0.3 | 96.5 | 100 |
≤ 0.4 | 97.2 | 100 |
≤ 0.5 | 96.4 | 100 |
≤ 0.6 | 97.0 | 100 |
≤ 0.7 | 95.0 | 99.1 |
≤ 0.8 | 95.0 | 99.1 |
≤ 1.0 | 93.1 | 99.1 |
> 1.0 | 90.7 | 99.1 |
Abbreviations: PAC, plasma aldosterone concentration; PRA, plasma renin activity.
Specificities of the Cutoff Value (PAC ≥ 30.85 ng/dL) for Predicting Positive Results in CCT or SIT Separately for Each Baseline PRA
Baseline PRA Levels (ng/mL/h) . | Specificity of the Cutoff Value (PAC ≥ 30.85 ng/dL) for Predicting Positive Result in Each Test (%) . | |
---|---|---|
. | Captopril Challenge Test . | Saline Infusion Test . |
≤ 0.3 | 96.5 | 100 |
≤ 0.4 | 97.2 | 100 |
≤ 0.5 | 96.4 | 100 |
≤ 0.6 | 97.0 | 100 |
≤ 0.7 | 95.0 | 99.1 |
≤ 0.8 | 95.0 | 99.1 |
≤ 1.0 | 93.1 | 99.1 |
> 1.0 | 90.7 | 99.1 |
Baseline PRA Levels (ng/mL/h) . | Specificity of the Cutoff Value (PAC ≥ 30.85 ng/dL) for Predicting Positive Result in Each Test (%) . | |
---|---|---|
. | Captopril Challenge Test . | Saline Infusion Test . |
≤ 0.3 | 96.5 | 100 |
≤ 0.4 | 97.2 | 100 |
≤ 0.5 | 96.4 | 100 |
≤ 0.6 | 97.0 | 100 |
≤ 0.7 | 95.0 | 99.1 |
≤ 0.8 | 95.0 | 99.1 |
≤ 1.0 | 93.1 | 99.1 |
> 1.0 | 90.7 | 99.1 |
Abbreviations: PAC, plasma aldosterone concentration; PRA, plasma renin activity.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.